PFE Pfizer
- 29.740
- +0.330+1.12%
- 29.720
- -0.020-0.07%
Pfizer News
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT
Pfizer | SC TO-I/A: Third party tender offer statement (Amendment)
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
Pfizer | SC TO-I: Issuer tender offer statement
Pfizer | 4: Statement of changes in beneficial ownership of securities- PFIZER INC
Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer”)(0.0%)
Pfizer | 10-Q: Q2 2024 Earnings Report
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer DAMICO JENNIFER B.
Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT
Pfizer | 3: Initial statement of beneficial ownership of securities-Officer Baum Andrew
Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer
Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer
Pfizer | 8-K: Pfizer's Financial Results for the Second Quarter of 2024
Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)
Analysis
Price Target
No Data
